These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7313357)

  • 41. Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
    Lui HK; Awan NA; Mason DT
    Herz; 1983 Apr; 8(2):65-70. PubMed ID: 6303929
    [No Abstract]   [Full Text] [Related]  

  • 42. [Favorable hemodynamic effects of captopril in chronic refractory congestive heart failure].
    Ansalone G; Bellocci F; Scabbia E; Schiavoni G; Loperfido F; Zecchi P
    Cardiologia; 1982; 27(3):263-9. PubMed ID: 6765431
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acute and chronic effects of dihydralazine in severe congestive heart failure at rest and during exercise (author's transl)].
    Reifart N; Bunge T; Kaltenbach M; Bussmann WD
    Z Kardiol; 1982 Jan; 71(2):75-81. PubMed ID: 6803467
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evaluation of prazosin in heart failure using exercise tests: short- and long-term results].
    Sánchez Domínguez J; Barciela Vilas R; Largo Aguado F; Urbina Fuentes FJ; González Villa J
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):17-21. PubMed ID: 6635272
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of prazosin on aortal regurgitation (author's transl)].
    Jebavý P; Koudelková E
    Cas Lek Cesk; 1980 Oct; 119(42):1132-7. PubMed ID: 7285074
    [No Abstract]   [Full Text] [Related]  

  • 46. [Vasodilator therapy in management of chronic heart failure (author's transl)].
    Letac B; Champoud O; Moore N
    Therapie; 1981; 36(1):1-10. PubMed ID: 7015550
    [No Abstract]   [Full Text] [Related]  

  • 47. [Acute and chronic effects of oral cardiotonic agent, denopamine (TA-064) in patients with heart failure].
    Inden M; Yamamuro M; Murayama S; Noda E; Tanimura H; Takasaki H; Konishi T; Nakano T; Takezawa H
    Kokyu To Junkan; 1986 May; 34(5):541-6. PubMed ID: 3738247
    [No Abstract]   [Full Text] [Related]  

  • 48. Danger of withdrawal of vasodilator therapy in patients with chronic heart-failure.
    Hanley SP; Cowley A; Hampton JR
    Lancet; 1980 Apr; 1(8171):735-6. PubMed ID: 6103157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
    Albillos A; Lledó JL; Bañares R; Rossi I; Iborra J; Calleja JL; Garrido A; Escartin P; Bosch J
    Hepatology; 1994 Sep; 20(3):611-7. PubMed ID: 7915703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical and polycardiographic evaluation of prazosin in the treatment of chronic congestive heart failure].
    Szmydt W; Kaftańska A; Paradowski S
    Pol Tyg Lek; 1984 Nov; 39(46):1509-12. PubMed ID: 6393093
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of vasodilators on resting and exercise hemodynamics in patients with chronic congestive heart failure (author's transl)].
    Higaki S; Tomiya H; Makita K; Fukuda T; Nakamura Y
    Kokyu To Junkan; 1981 Jun; 29(6):647-58. PubMed ID: 7313365
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hemodynamic and humoral effects of prazosin in patients with essential hypertension].
    Higa T; Kida O; Morotomi Y; Kodama K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1982 Aug; 24(8):937-45. PubMed ID: 7176188
    [No Abstract]   [Full Text] [Related]  

  • 53. [Study of hemodynamic and coronary effects induced by intravenous injection of disopyramide administered to coronary failure and congestive heart failure patients (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Morin D; Ourbak P; Maurice P
    Therapie; 1981; 36(2):179-86. PubMed ID: 7292392
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hemodynamic effects of combined isosorbide dinitrate-nifedipine therapy in congestive heart failure (author's transl)].
    Matsui S; Murakami E; Takekoshi N; Murakami H; Masuya K; Nomura M; Fujita S; Tsuji S; Chadani T
    Kokyu To Junkan; 1981 Sep; 29(9):965-70. PubMed ID: 7323483
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hemodynamic effects of hydralazine at rest and during exercise, in patients with congestive heart failure (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Stockins B; Saavedra J; Schulthess L
    Rev Med Chil; 1980 Jul; 108(7):599-604. PubMed ID: 7209179
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of prazosin in chronic cardiac insufficiency by external chronometry of the left ventricle].
    Sánchez Domínguez J; Largo F; Barciela R; Urbina FJ; Villa JG
    Rev Clin Esp; 1983 Mar; 168(5):343-6. PubMed ID: 6867409
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prazosin in the treatment of chronic resistant heart failure].
    Kleinman Y; Tzivoni D
    Harefuah; 1981 Apr; 100(8):398-401. PubMed ID: 7274816
    [No Abstract]   [Full Text] [Related]  

  • 58. [Acute myocardial infarction with pump failure: hemodynamic response to prazosin].
    Oliveri R; Cremades E; Bazzino O; Doval H
    Cardiology; 1980; 66 Suppl 2():193-201. PubMed ID: 7285030
    [No Abstract]   [Full Text] [Related]  

  • 59. [Administration of nitroprusside in the therapy of refractory cardiac failure (author's transl)].
    Nikolić V; Sjerobabski V; Barić L; Pilas V; Planinc D; Vukosavić D
    Lijec Vjesn; 1981 Nov; 103(11):495-500. PubMed ID: 7343794
    [No Abstract]   [Full Text] [Related]  

  • 60. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.